These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26318424)

  • 1. Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor.
    Sun NK; Huang SL; Lu HP; Chang TC; Chao CC
    Oncotarget; 2015 Sep; 6(29):27065-82. PubMed ID: 26318424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.
    Sun NK; Huang SL; Chang PY; Lu HP; Chao CC
    Oncotarget; 2014 Dec; 5(23):11939-56. PubMed ID: 25460502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells.
    Sun NK; Kohli A; Huang SL; Chang TC; Chao CC
    J Cell Physiol; 2019 Jun; 234(6):8760-8775. PubMed ID: 30317630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1.0 induces paclitaxel-resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor.
    Kohli A; Huang SL; Chang TC; Chao CC; Sun NK
    Cancer Sci; 2022 Aug; 113(8):2616-2626. PubMed ID: 35639349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.
    Sun NK; Huang SL; Chang TC; Chao CC
    J Cell Physiol; 2018 Mar; 233(3):2489-2501. PubMed ID: 28771725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells.
    Huang SL; Chang TC; Chao CCK; Sun NK
    Biochem Pharmacol; 2020 Jul; 177():113965. PubMed ID: 32278794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer.
    Huang SL; Chang TC; Chao CCK; Sun NK
    Biochem Pharmacol; 2021 Apr; 186():114456. PubMed ID: 33556340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
    Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation.
    Song Y; Peng X; Wang M; Xie J; Tan G
    Int J Clin Exp Pathol; 2015; 8(9):11314-22. PubMed ID: 26617855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity.
    Huang SL; Chang TC; Sun NK
    Biochem Pharmacol; 2023 Jun; 212():115581. PubMed ID: 37146834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Yang Y; Lu Y; Wang L; Mizokami A; Keller ET; Zhang J; Fu J
    Oncol Rep; 2016 Jul; 36(1):559-66. PubMed ID: 27175797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer.
    Li Y; Mizokami A; Izumi K; Narimoto K; Shima T; Zhang J; Dai J; Keller ET; Namiki M
    Prostate; 2010 Jan; 70(1):48-60. PubMed ID: 19725034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway.
    Zhang X; Ling MT; Wang X; Wong YC
    Int J Cancer; 2006 Apr; 118(8):2072-81. PubMed ID: 16287090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
    Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
    Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.